These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20848657)

  • 21. Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations.
    Ustündağ Okur N; Apaydın S; Karabay Yavaşoğlu NÜ; Yavaşoğlu A; Karasulu HY
    Int J Pharm; 2011 Sep; 416(1):136-44. PubMed ID: 21723930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled release of liposome-encapsulated Naproxen from core-sheath electrospun nanofibers.
    Li Z; Kang H; Che N; Liu Z; Li P; Li W; Zhang C; Cao C; Liu R; Huang Y
    Carbohydr Polym; 2014 Oct; 111():18-24. PubMed ID: 25037324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel biomaterial for transdermal application: in vitro and in vivo characterization.
    Mundada AS; Avari JG
    Drug Deliv; 2011 Aug; 18(6):424-31. PubMed ID: 21554152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrospun drug loaded membranes for sublingual administration of sumatriptan and naproxen.
    Vrbata P; Berka P; Stránská D; Doležal P; Musilová M; Čižinská L
    Int J Pharm; 2013 Nov; 457(1):168-76. PubMed ID: 24050988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An investigation of formulation factors affecting feasibility of alginate-chitosan microparticles for oral delivery of naproxen.
    Calija B; Cekić N; Savić S; Krajišnik D; Daniels R; Milić J
    Arch Pharm Res; 2011 Jun; 34(6):919-29. PubMed ID: 21725813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of concomitant drug release from oil vehicles using drug-prodrug combinations to achieve sustained balanced analgesia after joint installation.
    Thing M; Jensen SS; Larsen C; Østergaard J; Larsen SW
    Int J Pharm; 2012 Dec; 439(1-2):246-53. PubMed ID: 23010284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanosizing drug particles in supercritical fluid processing.
    Pathak P; Meziani MJ; Desai T; Sun YP
    J Am Chem Soc; 2004 Sep; 126(35):10842-3. PubMed ID: 15339159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Yang KH; Shin SC
    Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and irradiation of Pluronic F127-based thermoreversible and mucoadhesive hydrogel for local delivery of naproxen.
    Shin BK; Baek EJ; Choi SG; Davaa E; Nho YC; Lim YM; Park JS; Huh KM; Park JS
    Drug Dev Ind Pharm; 2013 Dec; 39(12):1874-80. PubMed ID: 22409199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of microparticles of naproxen with Eudragit RS and talc by spherical crystallization technique.
    Maghsoodi M; Esfahani M
    Pharm Dev Technol; 2009; 14(4):442-50. PubMed ID: 19235551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled release of atenolol from the ethylene-vinyl acetate matrix.
    Kim J; Shin SC
    Int J Pharm; 2004 Apr; 273(1-2):23-7. PubMed ID: 15010126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Micelle formation and drug release behavior of polypeptide graft copolymer and its mixture with polypeptide block copolymer.
    Lin J; Zhang S; Chen T; Lin S; Jin H
    Int J Pharm; 2007 May; 336(1):49-57. PubMed ID: 17134858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naproxen-Eudragit microspheres: screening of process and formulation variables for the preparation of extended release tablets.
    Zaghloul AA; Faltinek J; Vaithiyalingam SR; Reddy IK; Khan MA
    Pharmazie; 2001 Apr; 56(4):321-4. PubMed ID: 11338673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced delivery of naproxen to the viable epidermis from an activated poly N-isopropylacrylamide (PNIPAM) Nanogel: Skin penetration, modulation of COX-2 expression and rat paw oedema.
    Yurdasiper A; Ertan G; Heard CM
    Nanomedicine; 2018 Oct; 14(7):2051-2059. PubMed ID: 29958974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of electroporation and iontophoresis for percutaneous penetration of naproxen.
    Hu QH; Liang WQ
    Pharmazie; 2003 Mar; 58(3):192-4. PubMed ID: 12685812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Encapsulation and sustained release of a model drug, indomethacin, using CO(2)-based microencapsulation.
    Liu H; Finn N; Yates MZ
    Langmuir; 2005 Jan; 21(1):379-85. PubMed ID: 15620328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a novel ketoprofen transdermal patch: effect of almond oil as penetration enhancers on in-vitro and ex-vivo penetration of ketoprofen through rabbit skin.
    Hussain A; Khan GM; Shah SU; Shah KU; Rahim N; Wahab A; Rehman AU
    Pak J Pharm Sci; 2012 Jan; 25(1):227-32. PubMed ID: 22186334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Taste masking of naproxen sodium granules by fluid-bed coating.
    Stange U; Führling C; Gieseler H
    Pharm Dev Technol; 2014 Mar; 19(2):137-47. PubMed ID: 23324020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo skin permeation of sodium naproxen formulated in pluronic F-127 gels: effect of Azone and Transcutol.
    Escobar-Chávez JJ; Quintanar-Guerrero D; Ganem-Quintanar A
    Drug Dev Ind Pharm; 2005 May; 31(4-5):447-54. PubMed ID: 16093210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and physicochemical characterization of naproxen-PLGA nanoparticles.
    Javadzadeh Y; Ahadi F; Davaran S; Mohammadi G; Sabzevari A; Adibkia K
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):498-502. PubMed ID: 20719477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.